JNMT
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Figures Only
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tsushima, H.
Right arrow Articles by Onoguchi, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tsushima, H.
Right arrow Articles by Onoguchi, M.
Journal of Nuclear Medicine Technology Volume 34, Number 3, 2006 153-159
© 2006 by Society of Nuclear Medicine

Usefulness of Medium-Energy Collimator for Sentinel Node Lymphoscintigraphy Imaging in Breast Cancer Patients

Hiroyuki Tsushima, PhD1,2, Teruhiko Takayama, MD2, Takashi Yamanaga, RT1, Hiroto Kizu, PhD2, Yoshihiro Shimonishi, RT1, Kazuhisa Kosakai, RT1, Atsushi Noguchi, PhD2 and Masahisa Onoguchi, PhD2

1 Department of Radiological Technology, Osaka City University Hospital, Asahimachi, Abeno, Osaka, Japan; and 2 Department of Health Sciences, Graduate School of Medical Science, Kanazawa University, Kodatsuno, Kanazawa, Japan

Correspondence: For correspondence or reprints contact: Hiroyuki Tsushima, PhD, Department of Radiological Technology, Osaka City University Hospital, 1-5-7 Asahimachi, Abeno, Osaka 545-8586, Japan. E-mail: tsushima{at}med.osaka-cu.ac.jp

This study was performed to investigate the usefulness of a general-purpose medium-energy (ME) collimator for the accurate localization of the sentinel lymph node (SLN) in breast cancer patients. Methods: We compared phantom images and lymphoscintigraphy images obtained under different conditions for a patient with breast cancer. Comparisons were performed between 2 cameras, between a low-energy high-resolution (LEHR) collimator and a general-purpose ME collimator, and between energy windows centered at 141 keV and at 146 keV. Profile curves and image contrast were evaluated along with the visual interpretation of images. The most suitable imaging time was selected from the relationship between contrast and the data acquisition time. Results: The images obtained with the general-purpose ME collimator and the energy window centered at 141 keV were of poorer quality than those obtained with the LEHR collimator and the same energy window. However, the quality of the images obtained with the general-purpose ME collimator improved when the energy window was centered at 146 keV. The method involving the general-purpose ME collimator and the energy window centered at 146 keV showed excellent image quality similar to that obtained with the LEHR collimator. The enhancement of contrast was confirmed at more than 3 cm away from the center of the injection site. Stable contrast was obtained with a data acquisition time of 5 min, with the general-purpose ME collimator, and with the energy window centered at 146 keV. Conclusion: The method involving the general-purpose ME collimator and the energy window centered at 146 keV has the merit of the lymph node not being concealed by a lead shield. This new method is expected to improve the rate of detection of SLN and has the potential for shortening the acquisition time.

Key Words: sentinel lymph node; breast cancer; lymphoscintigraphy; medium-energy collimator; star-shaped artifacts







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE JOURNAL OF NUCLEAR MEDICINE JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY
Copyright © 2006 by the Society of Nuclear Medicine Technologist Section.